Puri Michal Nath — SEC Form 4 filings
SEC reporting owner CIK 1997032. 11 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-29 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 5 filings — 6,125 shares, $102,663 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 1,162 shares @ $19.92 ($23,149) in NovoCure Ltd, filed 2025-03-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NovoCure Ltd (NVCR) | Chief Human Resources Officer | 11 | — | 7 legs · 6,125 sh · $102,663 | 10 |
Form 4 filings — Puri Michal Nath
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 1,905 @ $11.15 | EDGAR |
| 2026-03-05 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 40,100 @ $0 · Sale (S): 1,100 @ $13.31 · Grant/award (A): 58,672 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | NovoCure Ltd (NVCR) | Sale (S): 1,441 @ $13.66 | EDGAR |
| 2025-11-04 | 4 | NovoCure Ltd (NVCR) | Tax withholding (F): 752 @ $12.82 | EDGAR |
| 2025-07-01 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 833 @ $15.13 | EDGAR |
| 2025-03-06 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 54,975 @ $18.19 · Grant/award (A): 81,499 (derivative) @ $18.19 | EDGAR |
| 2025-03-03 | 4/A | NovoCure Ltd (NVCR) | Sale (S): 1,162 @ $19.92 · Sale (S): 225 @ $20.55 | EDGAR |
| 2025-03-03 | 4 | NovoCure Ltd (NVCR) | Sale (S): 1,162 @ $19.92 · Sale (S): 225 @ $20.55 | EDGAR |
| 2024-11-04 | 4 | NovoCure Ltd (NVCR) | Sale (S): 810 @ $15.79 | EDGAR |
| 2024-08-06 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 1,736 @ $12.24 | EDGAR |
| 2024-02-29 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 71,574 @ $16.30 · Grant/award (A): 109,443 (derivative) @ $16.30 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1997032 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →